All In Biotech

Drug Trial Radar · NCT07250802

A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis

A Phase 3, Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial to Evaluate the Efficacy, Safety, Tolerability, and Pharmacokinetics of Zasocitinib in Pediatric Participants Aged 4 to Less Than 18 Years With Moderate-to-Severe Plaque Psoriasis

Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 210 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

210

Planned (sponsor's estimate)

Start

Dec 4, 2025

Primary completion

Jul 3, 2034

Study completion Jul 3, 2034

Sponsor

Lead sponsor
TakedaTakeda (TAK)
Sponsor type
Industry
First posted
Nov 26, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 4 years, up to 17 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The main aim of this study is to see how well the medicine zasocitinib works, how safe it is, and how children and teenagers aged 4 to under 18 with moderate-to-severe plaque psoriasis respond to it. The study will be done in 2 parts: Part A will include both children and teenagers, while part B will only include children. At first, only teenagers who meet the study rules can participate in this study. Children may only start to participate in Part A Cohort 2 once enough information has been collected from Part B to determine the appropriate dose. Participants in Part A will initially be assigned to receive either zasocitinib or placebo for the first 16 weeks of treatment, then all participants will receive zasocitinib through the end of the study. All participants in Part B will be assigned to receive treatment with zasocitinib throughout the study. Participants will be in the study for up to 4 years and 2 months (217 weeks), including up to 35 days for the screening period, 208 weeks of treatment (Part A and Part B) and a 4-week safety follow-up period. During the study, participants will visit their study site multiple times.

Conditions

  • Plaque Psoriasis

Interventions

  • ZasocitinibDrug

    Zasocitinib.

  • PlaceboDrug

    Zasocitinib matching placebo.

  • ZasocitinibDrug

    Zasocitinib.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Part A: Percentage of Participants Achieving a Static Physician's Global Assessment (sPGA) of Clear (0) or Almost Clear (1) With a Greater than or Equal to (>=) 2-Point Decrease From Baseline at Week 16Time frame: At Week 16
  2. Part A: Percentage of Participants Achieving >= 75 Percent (%) Improvement From Baseline in Psoriasis Area and Severity Index (PASI) Score at Week 16Time frame: At Week 16
  3. Part B: Maximum Observed Plasma Concentration (Cmax) of ZasocitinibTime frame: Pre-dose and Post-dose on Day 7
  4. Part B: Time to Maximum Concentration (Tmax) of ZasocitinibTime frame: Pre-dose and Post-dose on Day 7
  5. Part B: Area Under the Concentration-Time Curve From Time 0 to the Time of Last Quantifiable Concentration (AUC0-Last) of ZasocitinibTime frame: Pre-dose and Post-dose on Day 7

Locations

38 sites in 7 countries. Site status is shown where the registry gives one.

  • Exalt Clinical Research

    Chula Vista, California · Recruiting

  • First OC Dermatology Research Inc.

    Fountain Valley, California · Recruiting

  • Direct Helpers Medical Center

    Hialeah, Florida · Recruiting

  • Arlington Dermatology

    Rolling Meadows, Illinois · Recruiting

  • Apex Clinical Research Center, LLC

    Canton, Ohio · Recruiting

  • Wright State Physicians

    Fairborn, Ohio · Recruiting

  • Apex Clinical Research Center, LLC

    Mayfield Heights, Ohio · Recruiting

  • Medical University of South Carolina

    Charleston, South Carolina · Recruiting

  • UT Physicians Dermatology - Bellaire Station

    Bellaire, Texas · Recruiting

  • Texas Dermatology and Laser Specialists-San Antonio

    San Antonio, Texas · Recruiting

  • Medical College of Wisconsin

    Milwaukee, Wisconsin · Recruiting

  • Peking University Third Hospital

    Beijing, China · Recruiting

  • Huashan Hospital Fudan University

    Shanghai, China · Recruiting

  • Beijing Children Hospital, Capital Medical University

    Beijing, Beijing Municipality, China · Recruiting

  • Dermatology Hospital of Southern Medical University

    Guangzhou, Guangdong, China · Recruiting

  • Hunan Children's Hospital

    Changsha, Hunan, China · Recruiting

  • Hangzhou First People's Hospital

    Hangzhou, Zhejiang, China · Recruiting

  • Universitätsklinikum Bonn

    Bonn, Germany · Recruiting

  • Fachklinik Bad Bentheim

    Bad Bentheim, Lower Saxony, Germany · Recruiting

  • Uniklinik Koln, Klinik fur Dermatologie und Venerologie

    Cologne, North Rhine-Westphalia, Germany · Recruiting

  • University Hospital of Muenster

    Münster, North Rhine-Westphalia, Germany · Recruiting

  • Universita Degli Studi Di Padova

    Padova, Italy · Recruiting

  • Fondazione Policlinico Universitario Agostino Gemelli IRCCS

    Rome, Italy · Recruiting

  • Presidio Ospedaliero Gaspare Rodolico

    Catania, Sicily, Italy · Recruiting

  • Nagoya City University Hospital

    Nagoya, Aichi-ken, Japan · Recruiting

  • Hospital of the University of Occupational and Environmental Health, Japan

    Kitakyushu-shi, Fukuoka, Japan · Recruiting

  • Mie University Hospital

    Tsu, Mie, Mie-ken, Japan · Recruiting

  • Nippon Life Hospital

    Osaka, Osaka, Japan · Recruiting

  • Teikyo University Hospital

    tabashi City, Tokyo, Japan · Recruiting

  • "DERMED" Centrum Medyczne Sp. z o. o.

    Lodz, Poland · Recruiting

  • Dermoklinika-Centrum Medyczne s.c

    Lodz, Poland · Recruiting

  • Cityclinic Przychodnia lekarsko psychologiczna Matusiak sp.p

    Wroclaw, Lower Silesian Voivodeship, Poland · Recruiting

  • Luxderm Specjalistyczny Gabinet Dermatologiczny Dorota Krasowska

    Lublin, Lublin Voivodeship, Poland · Recruiting

  • Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie

    Rzeszów, Podkarpackie Voivodeship, Poland · Recruiting

  • Centrum Badan Klinicznych Pi-house Sp. Z O. O.

    Gdansk, Pomeranian Voivodeship, Poland · Recruiting

  • Hospital de La Santa Creu i Sant Pau - Dermatologia

    Barcelona, Spain · Recruiting

  • Hospital Universitario 12 de Octubre

    Madrid, Spain · Recruiting

  • Complejo Hospitalario Universitario de Santiago de Compostela

    Santiago de Compostela, A Coruna, Spain · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.